Application Notes

Incorporating Ultrashort-Chain PFAS into Comprehensive PFAS Analysis in Liquid Milks

11 Dec 2025

feature FSAN5396

Key Highlights

  • Simple, streamlined sample preparation protocol minimizes contamination and maximizes recovery.
  • Inert column hardware packed with a unique polar-embedded stationary phase and established method conditions provide accurate, precise results for the simultaneous analysis of ultrashort-chain, short-chain, medium-chain, long-chain, and alternative PFAS.
  • Proven suitable for comprehensive assessment of PFAS contamination across a diverse range of liquid milk samples.

Abstract

Incorporating ultrashort-chain PFAS into methods that also include short-chain, medium-chain, long-chain and alternative PFAS is essential for gaining a comprehensive assessment of PFAS contamination. The sample preparation and LC-MS/MS workflow established here provides an effective approach for quantitative monitoring of a diverse panel of PFAS, including ultrashort-chain analytes, in a wide range of milk matrices. The method was assessed based on linearity, accuracy, and precision parameters and then applied to real-world samples of various dairy milks; plant-based milks; and infant formula.

Introduction

Ultrashort-chain (USC) per- and polyfluoroalkyl substances (PFAS) are highly polar compounds with carbon chains shorter than C4 (Figure 1), and they are ubiquitous in aquatic environments. Their widespread occurrence has raised growing concerns about potential contamination in food products, particularly in ready-to-feed liquid milk products, which are widely consumed by infants and children. While effective methods exist for analyzing longer-chain PFAS in milk samples [1], to fully assess PFAS contamination, it is critical to include ultrashort-chain compounds.

Analyzing PFAS in milk poses unique challenges due to the complexity of the matrix, which contains proteins, fats, and other components that can interfere with detection. Ultrashort-chain PFAS and other shorter-chain compounds are particularly difficult to analyze, as traditional multi-step sample preparation methods can either contribute background PFAS contamination or lead to low recovery of the target analytes. In this study, a sample preparation procedure involving protein precipitation, extract dry-down, and reconstitution was developed and optimized for effective extraction and quantification of all analytes. In addition to sample preparation challenges, the high polarity of ultrashort-chain PFAS poses a significant difficulty for standard chromatographic practices in PFAS analysis, primarily due to insufficient chromatographic retention. The method developed here uses an inert-coated, polar-embedded, reversed-phase LC column to improve retention and sensitivity.

The combined sample preparation procedure and chromatographic method created a simple, reliable workflow for the simultaneous analysis of C1 to C14 perfluoroalkyl carboxylic and sulfonic acids, along with other PFAS classes, in various liquid milk matrices. Method verification was conducted using three different milk types (dairy milk; plant-based milk; and infant formula) to establish the workflow’s suitability for detecting 41 PFAS. In addition, the method was tested across a wide range of real-world milk samples, demonstrating its effectiveness in comprehensive profiling of PFAS contamination across diverse milk matrices.

Figure 1: Structures of Ultrashort-Chain PFAS (C1 to C3)

PFAS chemical structures

Experimental

Evaluation of Background Contamination of Ultrashort-Chain PFAS

Given the widespread presence of ultrashort-chain PFAS in aquatic systems, ensuring the cleanliness of laboratory reagents and materials is crucial for accurate analysis. In particular, background contamination of TFA is a major concern, as it can be present in solvents, reagents, and commonly used laboratory materials. Through extensive testing, the cleanest sources of water, acetonitrile, and methanol were identified for this study. Notably, significant variations in TFA detection signals were observed with different water sources used for the aqueous mobile phase, leading to the selection of ultrapure deionized water to ensure optimal sensitivity. Likewise, various pipette tips, HPLC vials, and centrifuge tubes used for standard and sample preparation were evaluated for contamination, allowing selection of the cleanest materials to maintain the integrity of our results.

Standard and Sample Preparation

Calibration standard solutions (500 µL) were prepared in polypropylene HPLC vials using a 1:1 mixture of reverse osmosis water and acetonitrile, with concentrations ranging from 4 to 2500 ng/L. Eighteen mass-labeled PFAS were used as quantitative internal standards (QIS) (Table I). A 2.5 µL aliquot of QIS working solution, containing 10 ng/mL of each isotope, was added to each standard solution. The milk samples (0.5 g) were weighed into 15-mL polypropylene centrifuge tubes, spiked with 2.5 µL of 10 ng/mL QIS working solution, thoroughly mixed, and extracted with 1.5 mL of acetonitrile by vortexing for 2 minutes. The mixture was then centrifuged at 4000 rpm, and then the supernatant was transferred to a new 15-mL tube and dried under a gentle nitrogen stream in a 50 °C water bath. The dried residue was reconstituted with 0.5 mL of a 1:1 water:acetonitrile diluent, vortexed for 2 minutes, and centrifuged again at 4000 rpm. The final supernatant was transferred to polypropylene HPLC vials for LC-MS/MS analysis.

Evaluation of Method Accuracy and Precision

To demonstrate that the developed workflow can be applied to various milk matrices, three types of ready-to-feed milk samples—dairy whole milk, almond milk, and infant formula—were used to evaluate method accuracy and precision. Almond milk was selected to represent the plant-based milk due to its widespread consumption. These milk samples were fortified with native analytes at concentrations of 0.010, 0.025, 0.050, 0.10, and 0.25 µg/kg, along with isotopically labeled 13C-TFA, which served as a surrogate for TFA recovery determination. These concentrations correspond to 10, 25, 50, 100, and 250 ng/L in the final sample solution following the sample preparation procedure described above. Incurred PFAS were detected in all three milk samples, and their concentrations were subtracted from the calculated concentrations of fortified samples to determine the recovery. Table I illustrates the pairing of QIS with various analytes for quantification. Due to differential matrix effects, some analytes in almond milk required alternative QIS for more accurate quantification.

Analytical Conditions

In this approach for incorporating ultrashort-chain PFAS and related compounds into a single method, analysis was performed by LC-MS/MS using a Waters ACQUITY UPLC I-Class liquid chromatograph and Xevo TQ-S triple quadrupole mass spectrometer under the conditions shown below. Ion transitions, MS settings, and the internal standard used to quantify each PFAS are given in Table I.  An Ultra IBD column (150 × 2.1 mm, 3.0 µm) was employed as the delay column to more effectively remove background contamination originating from the instrument and mobile phases. Although a standard C18 PFAS delay column is typically adequate, it did not provide acceptable separation between background contaminants and target analytes when coupled with the Ultra Inert IBD analytical column.

Columns:
– Analytical column: Ultra Inert IBD, 3.0 µm, 100 x 2.1 mm (cat.# 9175312-T)
– Delay column: Ultra IBD, 3.0 µm, 150 x 2.1 mm (cat.# 9175362)
Injection volume: 5 µL
Mobile phase A: 5 mM ammonium formate, 0.1% formic acid in water
Mobile phase B: Acetonitrile
Flow rate: 0.4 mL/min
Temperature: 40 °C
Gradient:  
Time (min)       %B
0.00                     45
7.00                     95
11.00                  95
11.01                  45
13.00                  45
Ion mode: Negative ESI
Mode: Scheduled MRM

Table I: MS/MS Parameters and Internal Standards

CompoundsRetention Time (min)Precursor IonProduct IonsaCone (V)Collision (V)QIS
Target Analytes
Perfluoroalkyl Carboxylic Acids
Trifluoroacetic acid (TFA) 1.60 113.03 [M-H]- 69.01 10 10 13C2-TFA
Perfluoropropanoic acid (PFPrA) 2.21 162.97 [M-H]- 119.02 10 8 13C3-PFPrA
Perfluorobutanoic acid (PFBA) 2.86 213.03 [M-H]- 168.98 14 8 13C4-PFBA
Perfluoropentanoic acid (PFPeA) 3.64 262.97 [M-H]- 218.97 2 6 13C5-PFPeA
Perfluorohexanoic acid (PFHxA) 4.41 313.10 [M-H]- 268.97/118.99 2 8/20 13C5-PFHxA
Perfluoroheptanoic acid (PFHpA) 5.15 363.16 [M-H]- 319.09/169.06 8 10/18 13C4-PFHpA
Perfluorooctanoic acid (PFOA) 5.84 413.10 [M-H]- 368.96/168.90 2 10/16 13C8-PFOA
Perfluorononanoic acid (PFNA) 6.48 463.10 [M-H]- 419.01/219.02 4 10/16 13C9PFNA
Perfluorodecanoic acid (PFDA) 7.08 513.17 [M-H]- 469.16/219.06 4 12/16 13C6-PFDA
Perfluoroundecanoic acid (PFUnA) 7.65 563.23 [M-H]- 519.24/269.07 6 12/18 13C7-PFUnA
Perfluorododecanoic acid (PFDoA) 8.26 613.23 [M-H]- 569.19/169.06 8 12/26 13C2-PFDoA
Perfluorotridecanoic acid (PFTrDA) 8.94 663.23 [M-H]- 619.21/169.06 8 14/28 13C2-PFTeDA
Perfluorotetradecanoic acid (PFTeDA) 9.75 712.67 [M-H]- 668.69/168.94 10 12/26 13C2-PFTeDA
Perfluoroalkyl Sulfonic Acids
Trifluoromethanesulfonic acid (TFMS) 1.98 148.97 [M-H]- 79.93/98.92 62 18/18 13C3-PFBS
Perfluoroethanesulfonic acid (PFEtS) 2.62 198.90 [M-H]- 79.92/98.91 38 22/22 13C4-PFBA
Perfluoropropanesulfonic acid (PFPrS) 3.30 248.97 [M-H]- 79.92/98.91 2 24/24 13C5-PFPeA
Perfluorobutanesulfonic acid (PFBS) 3.96 298.97 [M-H]- 79.97/98.89 2 26/26 13C3-PFBS
Perfluoropentanesulfonic acid (PFPeS) 4.59 349.10 [M-H]- 79.98/98.98 6 32/30 13C5-PFHxA / 13C8-PFOSb
Perfluorohexanesulfonic acid (PFHxS) 5.17 398.90 [M-H]- 79.97/98.89 56 32/34 13C3-PFHxS
Perfluoroheptanesulfonic acid (PFHpS) 5.70 449.17 [M-H]- 79.98/98.97 4 42/38 13C8-PFOA
Perfluorooctanesulfonic acid (PFOS) 6.19 499.03 [M-H]- 79.92/98.90 8 40/40 13C8-PFOS
Perfluorononanesulfonic acid (PFNS) 6.65 549.10 [M-H]- 79.92/98.83 12 42/40 13C8-PFOS
Perfluorodecanesulfonic acid (PFDS) 7.06 599.17 [M-H]- 79.98/98.83 8 44/46 13C8-PFOS / 13C2-PFDoAb
Perfluoroundecanesulfonic acid (PFUdS) 7.43 648.73 [M-H]- 79.94/98.94 38 50/44 13C8-PFOS / 13C2-PFDoAb
Perfluorododecanesulfonic acid (PFDoS) 7.77 698.77 [M-H]- 79.95/98.94 10 60/44 13C8-PFOS / 13C2-PFDoAb
Perfluorotridecanesulfonic acid (PFTrDS) 8.08 748.73 [M-H]- 79.94/98.94 8 76/52 13C8-PFOS / 13C2-PFDoAb
Fluorotelomer Sulfonic Acids
1H,1H,2H,2H-Perfluorohexane sulfonic acid (4:2 FTS) 3.92 327.10 [M-H]- 307.08/80.83 50 18/24 13C4-PFBA / 13C5-PFHxAb
1H,1H,2H,2H-Perfluorooctane sulfonic acid (6:2 FTS) 5.57 427.17 [M-H]- 407.18/80.71 2 22/32 13C8-PFOA
1H,1H,2H,2H-Perfluorodecane sulfonic acid (8:2 FTS) 7.07 527.17 [M-H]- 507.16/80.83 66 26/32 13C3-PFHxS / d5-NEtFOSAAb
Perfluoroalkyl Sulfonamides
Perfluorooctanesulfonamide (FOSA) 4.01 498.17 [M-H]- 77.97/477.76 8 28/26 13C8-FOSA
Perfluoroalkyl Sulfonamidoacetic Acids
N-methyl perfluorooctanesulfonamidoacetic acid (NMeFOSAA) 6.40 570.20 [M-H]- 419.17/483.16 46 20/14 d3-NMeFOSAA
N-ethyl perfluorooctanesulfonamidoacetic acid (NEtFOSAA) 6.52 584.20 [M-H]- 419.18/483.11 6 20/16 d5-NEtFOSAA
Per- and Polyfluoroether Carboxylic Acids
Perfluoro-3-methoxypropanoic acid (PFMPA) 3.05 228.93 [M-H]- 84.97/198.94 10 10/14 13C4-PFBA
Perfluoro-4-methoxybutanoic acid (PFMBA) 3.76 278.87 [M-H]- 84.96/234.93 8 10/6 13C5-PFPeA
Hexafluoropropylene oxide dimer acid (HFPO-DA) 4.37 285.03 [M-COOH]- 169.02/185.02 2 6/16 13C5-PFHxA
4,8-Dioxa-3H-perfluorononanoic acid (ADONA) 4.71 376.90 [M-H]- 250.93/84.97 22 12/26 13C4-PFHpA
Per- and Polyfluoroether Sulfonic Acids
Perfluoro(2-ethoxyethane)sulfonic acid (PFEESA) 4.09 314.83 [M-H]- 134.94/83.01 4 22/16 13C3-PFBS
9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid (9Cl-PF3ONS) 6.20 530.78 [M-H]- 350.85/82.96 12 26/24 13C8-PFOA
11-Chloroeicosafluoro-3-oxaundecane-1-sulfonic acid (11Cl-PF3OUdS) 6.92 630.78 [M-H]- 450.80/82.95 8 26/32 13C8-PFOS
Capstone Surfactants
Capstone A 0.95 527.08 [M-H]- 507.02/181.06 2 10/12 13C2-TFA / 13C3-PFPrAb
Capstone B 1.90 569.07 [M-H]- 549.01/445.96 32 12/16 13C3-PFPrA
Quantification Internal Standards
13C2-TFA 2.69 114.90 [M-H]- 69.95 14 8
13C3-PFPrA 2.69 165.97 [M-H]- 120.96 10 11
13C4-PFBA 3.27 217.03 [M-H]- 171.98 2 8
13C5-PFPeA 3.94 267.97 [M-H]- 222.99 2 6
13C5-PFHxA 4.59 318.03 [M-H]- 272.93 2 7
13C4-PFHpA 5.24 366.90 [M-H]- 321.93 2 10
13C8-PFOA 5.86 420.97 [M-H]- 375.94 2 10
13C9PFNA 5.86 471.97 [M-H]- 426.87 4 12
13C6-PFDA 7.03 518.90 [M-H]- 473.87 4 13
13C7-PFUnA 7.60 569.90 [M-H]- 524.87 2 12
13C2-PFDoA 8.23 614.84 [M-H]- 569.87 2 12
13C2-PFTeDA 9.83 714.78 [M-H]- 669.80 8 14
13C3-PFBS 3.97 301.97 [M-H]- 79.97 2 28
13C3-PFHxS 5.01 401.90 [M-H]- 79.97 2 36
13C8-PFOS 5.96 506.84 [M-H]- 79.97 4 42
13C8-FOSA 3.36 505.91 [M-H]- 77.95 4 32
d3-NMeFOSAA 6.44 572.90 [M-H]- 418.91 50 18
d5-NEtFOSAA 6.56 588.97 [M-H]- 418.86 48 20
aQuantifier ion/qualifier ion
bUsed for quantification in almond milk

Results and Discussion

Chromatographic Performance

Analytical methods were previously developed for incorporating ultrashort-chain PFAS into comprehensive methods for testing PFAS in various water matrices [2] and human blood [3]. These methods utilized a polar-embedded alkyl Ultra IBD stationary phase to ensure adequate retention of highly polar ultrashort-chain PFAS. Additionally, it was demonstrated that an inert-coated Ultra IBD column could significantly enhance detection sensitivity for the majority of PFAS compounds [2] because it is made with hardware treated with an inert coating that prevents any unwanted analyte interactions with the stainless-steel surface of the column. The current study also applied a similar chromatographic methodology for PFAS analysis in milk samples. However, due to stronger matrix interference compared to water matrices, the injection volume was limited to 5 µL to maintain optimal chromatographic peak shapes for early-eluting compounds.

Figure 2 shows a typical chromatogram for the analysis of a fortified milk sample. In addition to the 28 PFAS compounds assessed under EURL guidance [4], this analysis was expanded to 41 analytes by incorporating ultrashort-chain PFAS, fluorotelomer sulfonic acids, and a broader range of alternative PFAS compounds. The EURL guidance notes that bile acids, such as tauroursodeoxycholic acid (TUDCA); taurochenodeoxycholic acid (TCDCA); and taurodeoxycholic acid (TDCA) can be present at high concentrations in milk samples and may interfere with PFOS quantification due to their shared mass transitions. Our tests confirmed that TUDCA, TCDCA, and TDCA all had distinct retention times from PFOS, ensuring they will not influence the accuracy of PFOS results (Figure 3). Furthermore, these bile acids displayed significantly lower detection sensitivity (~100-fold lower) than PFOS and were not detected in the final milk sample solutions analyzed in this study.

Figure 2: Analysis of a 0.1 µg/kg Fortified Whole Milk Sample

Integrating Ultrashort-Chain Compounds into Comprehensive PFAS Analysis in Liquid Milk

LC_FS0563

Peaks

PeakstR (min)Precursor IonQuantification IonConfirmation Ion
1.Capstone A0.95527.08507.02181.06
2.Trifluoroacetic acid (TFA)1.60113.0369.01
3.13C-Trifluoroacetic acid (13C-TFA)1.60114.0369.03
4.Capstone B 1.90569.07549.01445.96
5.Trifluoromethanesulfonic acid (TFMS)1.98148.9779.9398.92
6.Perfluoropropanoic acid (PFPrA)2.21162.97119.02
7.Perfluoroethanesulfonic acid (PFEtS)2.62198.9079.9298.91
8.Perfluoro-3-methoxypropanoic acid (PFMPA)3.05228.9384.97198.94
9.Perfluoropropanesulfonic acid (PFPrS)3.30248.9779.9298.91
10.Perfluoropentanoic acid (PFPeA)3.64262.97218.97
11.Perfluoro-4-methoxybutanoic acid (PFMBA)3.76278.8784.96234.93
12.1H,1H,2H,2H-Perfluorohexane sulfonic acid (4:2 FTS)3.92327.10307.0880.83
13.Perfluorobutanesulfonic acid (PFBS)3.96298.9779.9798.89
14.Perfluorooctanesulfonamide (FOSA)4.01498.1777.97477.76
15.Perfluoro(2-ethoxyethane)sulfonic acid (PFEESA)4.09314.83134.9483.01
16.Hexafluoropropylene oxide dimer acid (HFPO-DA)4.37285.03169.02185.02
17.Perfluorohexanoic acid (PFHxA)4.41313.10268.97118.99
18.Perfluoropentanesulfonic acid (PFPeS)4.59349.1079.9898.98
19.4,8-Dioxa-3H-perfluorononanoic acid (ADONA)4.71376.90250.9384.97
20.Perfluoroheptanoic acid (PFHpA)5.15363.16319.09169.06
PeakstR (min)Precursor IonQuantification IonConfirmation Ion
21.Perfluorohexanesulfonic acid (PFHxS)5.17398.9079.9798.89
22.1H,1H,2H,2H-Perfluorooctane sulfonic acid (6:2 FTS)5.57427.17407.1880.71
23.Perfluoroheptanesulfonic acid (PFHpS)5.70449.1779.9898.97
24.Perfluorooctanoic acid (PFOA)5.84413.10368.96168.90
25.Perfluorooctanesulfonic acid (PFOS)6.19499.0379.9298.90
26.9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid (9Cl-PF3ONS)6.20530.78350.8582.96
27.N-methyl perfluorooctanesulfonamidoacetic acid (NMeFOSAA)6.40570.20419.17483.16
28.Perfluorononanoic acid (PFNA)6.48463.10419.01219.02
29.N-ethyl perfluorooctanesulfonamidoacetic acid (NEtFOSAA)6.52584.20419.18483.11
30.Perfluorononanesulfonic acid (PFNS)6.65549.1079.9298.83
31.11-Chloroeicosafluoro-3-oxaundecane-1-sulfonic acid (11Cl-PF3OUdS)6.92630.78450.8082.95
32.Perfluorodecanesulfonic acid (PFDS)7.06599.1779.9898.83
33.1H,1H,2H,2H-Perfluorodecane sulfonic acid (8:2 FTS)7.07527.17507.1680.83
34.Perfluorodecanoic acid (PFDA)7.08513.17469.16219.06
35.Perfluoroundecanesulfonic acid (PFUdS)7.43648.7379.9498.94
36.Perfluoroundecanoic acid (PFUnA)7.65563.23519.24269.07
37.Perfluorododecanesulfonic acid (PFDoS)7.77698.7779.9598.94
38.Perfluorotridecanesulfonic acid (PFTrDS)8.08748.7379.9498.94
39.Perfluorododecanoic acid (PFDoA)8.26613.23569.19169.06
40.Perfluorotridecanoic acid (PFTrDA)8.94663.23619.21169.06
41.Perfluorotetradecanoic acid (PFTeDA)9.75712.67668.69168.94

Conditions

ColumnUltra Inert IBD (cat.# 9175312-T)
Dimensions:100 mm x 2.1 mm ID
Particle Size:3 µm
Pore Size:100 Å
Temp.:40 °C
Standard/Sample
PFAS 28 calibration standard (cat.# 30734)
Other standards were obtained externally
Other standards were obtained externally
Diluent:50:50 water:acetonitrile
Conc.: Whole milk fortified at 0.1 μg/kg
Inj. Vol.:5 µL
Mobile Phase
A:Water, 5mM ammonium formate, 0.1% formic acid
B:Acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.45545
7.000.4595
11.000.4595
11.010.45545
13.000.45545
Max Pressure:540 bar
DetectorWaters Xevo TQ-S
Ion Source:Waters Zspray ESI
Ion Mode:ESI-
Mode:MRM
InstrumentWaters ACQUITY UPLC I-Class
Sample PreparationMilk samples (0.5 g) were weighed into 15 mL polypropylene centrifuge tubes, spiked with analytes at 0.1 μg/kg, thoroughly mixed, and extracted with 1.5 mL of acetonitrile by vortexing for 2 minutes. The mixture was then centrifuged at 4000 rpm, and the supernatant was transferred to a new 15 mL tube and dried under a gentle nitrogen stream in a 50°C water bath. The dried residue was reconstituted with 0.5 mL of a 1:1 water:acetonitrile diluent, vortexed for 2 minutes, and centrifuged again at 4000 rpm. The final supernatant was transferred to polypropylene HPLC vials for LC-MS/MS analysis.
NotesThe confirmation ion peaks were not shown in the chromatogram.

An Ultra IBD column (150 x 2.1 mm, 3.0 μm; cat # 9175362) was used as the delay column.


For the chromatograms of perfluoroalkyl carboxylic and sulfonic acids, the peak numbers correspond to the carbon chain lengths of the PFAS compounds.

Figure 3: Full Chromatographic Separation of PFOS and Potentially Interfering Bile Acids

Distinct Retention Times Between PFOS and Bile Acids

LC_FS0565

Peaks

PeakstR (min)Conc.
(ng/mL)
Precursor IonConfirmation Ion
1.Tauroursodeoxycholic acid (TUDCA)4.50100499.0379.92
2.Perfluorooctanesulfonic acid (PFOS)6.050.5499.0379.92
3.Taurochenodeoxycholic acid (TCDCA)6.55100499.0379.92
4.Taurodeoxycholic acid (TDCA)6.74100499.0379.92

Conditions

ColumnUltra Inert IBD (cat.# 9175312-T)
Dimensions:100 mm x 2.1 mm ID
Particle Size:3 µm
Pore Size:100 Å
Temp.:40 °C
Standard/SampleIndividual standards were obtained externally.
Diluent:50:50 water:acetonitrile
Inj. Vol.:5 µL
Mobile Phase
A:Water, 5 mM ammonium formate, 0.1% formic acid
B:Acetonitrile
Time (min)Flow (mL/min)%A%B
0.000.45545
7.000.4595
11.000.4595
11.010.45545
13.000.45545
Max Pressure:540 bar
DetectorWaters Xevo TQ-S
Ion Source:Waters Zspray ESI
Ion Mode:ESI-
Mode:MRM
InstrumentWaters ACQUITY UPLC I-Class
Sample PreparationIndividual standards were prepared in 50:50 water:acetonitrile solution in polypropylene HPLC vials.
NotesAn Ultra IBD column (150 x 2.1 mm, 3.0 μm; cat # 9175362) was used as the delay column.

Linearity

Employing quadratic regression (1/x weighted), all analytes exhibited acceptable linearities with r2 >0.995 and deviations <30%. The calibration ranges were 20–2500 ng/L for TFA; 20–1000 ng/L for HFPO-DA, capstone A, and capstone B; and 4–1000 ng/L for the remaining analytes.

Accuracy and Precision

Three batches of analyses were conducted on different days, totaling nine replicates at each fortified level. The average recovery and relative standard deviation (RSD) for each PFAS in each matrix are presented in Table III. All analytes exhibited recovery values within the range of 78.3–119% in whole milk; 81.6–129% in almond milk; and 80.5–118% in infant formula. Satisfactory method precision was demonstrated by the %RSD values being ≤15%. Due to higher matrix suppression or poor detection signals, the recovery of 13C-TFA; PFPrA; FOSA; HFPO-DA; capstone A; capstone B; and PFMPA could not be determined in some or all of the 0.01 µg/kg fortified samples. Capstone A could not be identified and measured in almond milk due to specific matrix suppression.

Table III: Accuracy and Precision Analysis of PFAS in Fortified Milk Samples

Whole Milk

Average Recovery (RSD, %), n=9
Fortified Concentration (µg/kg)
Analytes 0.010 0.025 0.050 0.10 0.25
13C-TFA 104 (9.40) 108 (6.19) 111 (7.65) 114 (6.02)
PFPrA 110 (9.22) 108 (9.29) 114 (5.59) 112 (7.55) 119 (4.73)
PFBA 115 (3.43) 104 (6.80) 111 (8.73) 108 (4.26) 112 (3.60)
PFPeA 106 (8.48) 91.3 (8.68) 92.0 (10.0) 97.5 (12.4) 102 (6.73)
PFHxA 108 (4.27) 87.9 (7.77) 92.6 (9.97) 90.9 (10.8) 105 (5.71)
PFHpA 113 (4.65) 93.7 (6.82) 92.1 (8.58) 90.3 (6.51) 103 (9.38)
PFOA 112 (9.69) 91.6 (12.9) 83.3 (11.4) 86.9 (4.64) 103 (10.5)
PFNA 114 (7.32) 102 (7.47) 101 (6.33) 105 (5.50) 110 (4.46)
PFDA 110 (10.7) 86.4 (8.71) 88.8 (8.37) 95.3 (10.8) 103 (9.83)
PFUnA 109 (8.75) 87.3 (11.8) 95.1 (9.90) 95.0 (10.7) 96.4 (13.9)
PFDoA 113 (7.22) 81.7 (8.30) 88.5 (9.97) 93.6 (6.06) 97.5 (15.0)
PFTrDA 113 (8.61) 85.4 (4.62) 86.7 (4.92) 95.2 (9.83) 95.4 (3.12)
PFTeDA 105 (13.5) 78.9 (7.25) 85.1 (12.2) 96.1 (8.25) 98.3 (15.1)
TFMS 112 (7.81) 107 (10.4) 112 (5.96) 82.9 (5.82) 84.6 (7.92)
PFEtS 104 (9.39) 103 (7.51) 105 (7.90) 114 (5.96) 116 (5.55)
PFPrS 95.7 (5.72) 87.6 (7.53) 94.5 (5.08) 91.3 (12.9) 99.7 (7.59)
PFBS 104 (12.7) 95.8 (13.0) 99.1 (9.98) 100 (10.3) 109 (8.59)
PFPeS 102 (9.04) 93.5 (12.4) 90.2 (11.5) 93.8 (14.0) 107 (13.5)
PFHxS 104 (8.83) 90.6 (12.4) 85.2 (8.26) 88.2 (8.90) 108 (10.4)
PFHpS 85.9 (4.54) 85.0 (4.97) 84.6 (8.85) 83.5 (3.94) 97.4 (10.0)
PFOS 109 (6.76) 102 (10.3) 102 (7.83) 93.0 (13.7) 102 (10.5)
PFNS 104 (10.8) 88.4 (11.0) 96.8 (14.1) 86.9 (5.59) 103 (10.4)
PFDS 98.5 (12.7) 91.7 (12.0) 97.3 (13.5) 95.8 (14.3) 106 (7.60)
PFUdS 86.1 (5.93) 93.1 (7.89) 105 (10.9) 91.0 (8.73) 108 (6.82)
PFDoS 116 (3.54) 78.3 (8.12) 101 (7.02) 86.5 (9.40) 102 (9.72)
PFTrDS 95.7 (14.4) 81.0 (2.20) 93.3 (6.78) 91.7 (13.2) 106 (10.5)
4:2 FTS 103 (8.31) 102 (12.1) 102 (10.2) 113 (8.30) 116 (2.94)
6:2 FTS 108 (9.23) 115 (6.07) 96.4 (9.84) 87.9 (10.2) 109 (5.90)
8:2 FTS 92.5 (15.3) 94.2 (12.3) 90.5 (7.92) 83.1 (5.62) 95.0 (8.98)
FOSA 103 (8.53) 88.3 (12.9) 96.3 (13.2) 112 (6.15)
NMeFOSAA 107 (9.71) 86.6 (8.05) 86.1 (8.46) 92.4 (10.7) 98.9 (12.9)
NEtFOSAA 107 (7.37) 94.3 (8.12) 94.8 (10.6) 105 (7.31) 110 (5.73)
PFMPA 86.1 (9.47) 88.4 (8.49) 84.0 (9.50) 85.4 (5.55) 90.4 (7.52)
PFMBA 87.4 (10.3) 98.5 (11.8) 85.8 (8.29) 98.6 (8.80) 102 (5.72)
HFPO-DA 98.7 (13.5) 96.9 (9.14) 88.2 (15.1) 98.6 (14.0)
ADONA 113 (4.56) 87.7 (7.80) 85.9 (7.20) 84.5 (1.90) 91.5 (8.03)
PFEESA 94.1 (10.6) 91.2 (12.4) 98.4 (11.7) 104 (8.42) 110 (7.01)
9Cl-PF3ONS 93.2 (7.90) 80.5 (7.82) 83.7 (5.62) 88.6 (5.48) 97.2 (11.2)
11Cl-PF3OUdS 99.8 (8.00) 82.3 (6.39) 92.4 (9.85) 101 (13.3) 106 (8.15)
Capstone A 85.9 (11.8) 103 (9.31) 111 (5.74) 118 (6.80)
Capstone B 108 (8.60) 99.9 (15.0) 113 (4.46) 118 (2.83)

Almond Milk

Average Recovery (RSD, %), n=9
Fortified Concentration (µg/kg)
Analytes 0.010 0.025 0.050 0.10 0.25
13C-TFA 127 (4.47) 129 (2.78) 125 (7.85) 110 (8.27)
PFPrA 120 (5.45) 115 (6.71) 114 (5.40) 119 (5.62)
PFBA 112 (7.95) 106 (8.08) 103 (8.48) 98.0 (6.45) 101 (14.2)
PFPeA 97.1 (7.51) 101 (10.8) 99.5 (10.8) 92.1 (8.40) 95.4 (7.09)
PFHxA 90.8 (12.2) 111 (10.1) 100 (7.90) 94.0 (6.60) 102 (9.41)
PFHpA 116 (5.79) 98.8 (6.45) 88.9 (5.97) 87.4 (6.15) 94.1 (6.10)
PFOA 109 (7.29) 113 (6.75) 102 (6.76) 109 (3.37) 114 (3.33)
PFNA 88.0 (8.26) 90.0 (7.59) 81.6 (6.43) 84.6 (4.29) 89.7 (7.17)
PFDA 106 (14.3) 95.0 (7.55) 84.7 (5.31) 92.6 (5.61) 94.2 (3.03)
PFUnA 105 (9.34) 93.4 (8.81) 99.1 (11.7) 108 (6.58) 106 (4.40)
PFDoA 115 (4.66) 114 (3.60) 114 (5.06) 119 (2.60) 119 (2.65)
PFTrDA 105 (8.08) 111 (4.47) 116 (6.70) 126 (3.29) 125 (3.64)
PFTeDA 106 (6.29) 112 (3.62) 118 (2.81) 128 (3.46) 128 (3.19)
TFMS 100 (9.22) 107 (7.45) 110 (4.41) 87.9 (5.54) 88.9 (8.59)
PFEtS 115 (6.22) 111 (7.45) 118 (3.40) 112 (6.29) 118 (3.93)
PFPrS 91.9 (8.44) 92.3 (5.94) 100 (8.15) 95.5 (4.92) 98.3 (7.83)
PFBS 112 (6.31) 92.1 (11.8) 98.9 (8.42) 90.1 (7.68) 101 (10.6)
PFPeS 99.7 (13.6) 111 (10.9) 103 (7.36) 100 (10.0) 106 (11.5)
PFHxS 100 (9.16) 95.9 (9.88) 101 (10.4) 111 (6.40) 108 (5.15)
PFHpS 86.9 (6.71) 96.0 (9.84) 84.5 (5.45) 92.1 (3.27) 99.5 (5.34)
PFOS 115 (4.37) 90.3 (10.9) 83.4 (5.20) 83.7 (7.66) 91.3 (8.34)
PFNS 89.6 (12.1) 92.3 (11.3) 82.8 (5.36) 95.0 (6.73) 93.0 (10.6)
PFDS 108 (12.8) 101 (11.6) 110 (5.53) 110 (9.70) 119 (3.14)
PFUdS 93.9 (11.4) 93.8 (9.55) 98.4 (7.86) 115 (1.83) 118 (3.13)
PFDoS 90.3 (7.00) 100 (9.86) 107 (6.95) 118 (2.42) 118 (2.26)
PFTrDS 95.9 (10.9) 94.0 (9.28) 99.6 (6.13) 114 (3.42) 115 (3.09)
4:2 FTS 87.6 (7.37) 108 (7.99) 105 (8.12) 99.7 (8.11) 105 (8.52)
6:2 FTS 113 (6.80) 113 (6.76) 110 (5.34) 105 (6.80) 105 (5.44)
8:2 FTS 118 (3.57) 101 (8.58) 96.4 (7.93) 108 (4.60) 103 (6.98)
FOSA 105 (12.5) 103 (7.55) 107 (6.24) 97.7 (10.6) 109 (5.68)
NMeFOSAA 105 (5.69) 92.2 (13.1) 87.0 (7.11) 91.8 (8.89) 98.0 (8.37)
NEtFOSAA 108 (7.59) 103 (9.82) 88.1 (9.60) 101 (10.5) 104 (6.61)
PFMPA 88.7 (6.82) 93.8 (9.95) 97.8 (13.1) 97.2 (9.27) 109 (5.00)
PFMBA 94.1 (11.1) 90.9 (10.4) 96.1 (9.65) 98.9 (6.79) 107 (6.54)
HFPO-DA 107 (9.78) 103 (10.2) 105 (11.1) 112 (5.38)
ADONA 101 (13.8) 104 (8.18) 88.0 (7.00) 83.8 (7.37) 89.8 (5.29)
PFEESA 103 (13.6) 95.2 (8.88) 97.2 (10.9) 94.9 (7.39) 101 (10.3)
9Cl-PF3ONS 108 (8.15) 96.7 (3.42) 81.7 (3.82) 95.0 (4.48) 94.2 (5.43)
11Cl-PF3OUdS 86.7 (8.10) 92.9 (8.10) 82.9 (2.81) 85.7 (3.71) 84.0 (9.17)
Capstone A
Capstone B 104 (7.55) 95.0 (14.0) 105 (9.55) 92.6 (11.2)

Infant Formula

Average Recovery (RSD, %), n=9
Fortified Concentration (µg/kg)
Analytes 0.010 0.025 0.050 0.10 0.25
13C-TFA 95.8 (12.9) 102 (6.25) 110 (10.2) 110 (9.68)
PFPrA 96.6 (8.80) 99.2 (7.87) 92.0 (4.92) 116 (4.05)
PFBA 107 (7.01) 107 (8.41) 108 (4.84) 110 (4.96) 109 (4.42)
PFPeA 93.1 (6.70) 99.7 (9.51) 99.8 (9.22) 88.3 (7.39) 99.3 (6.81)
PFHxA 101 (8.37) 94.5 (10.6) 99.9 (7.70) 98.5 (4.85) 106 (7.37)
PFHpA 94.0 (9.15) 98.6 (8.38) 99.6 (7.19) 97.0 (8.02) 104 (6.90)
PFOA 97.2 (11.7) 102 (10.9) 103 (5.99) 105 (6.93) 110 (3.65)
PFNA 101 (5.60) 97.0 (5.33) 107 (4.99) 110 (5.07) 116 (4.24)
PFDA 91.4 (6.59) 89.9 (6.39) 110 (4.69) 116 (3.48) 113 (1.86)
PFUnA 99.1 (10.8) 86.8 (4.92) 105 (7.70) 116 (3.81) 112 (7.38)
PFDoA 82.7 (3.01) 82.2 (2.66) 96.4 (3.87) 106 (4.87) 106 (4.39)
PFTrDA 86.2 (3.82) 81.5 (1.67) 96.2 (6.82) 96.9 (4.46) 113 (5.98)
PFTeDA 81.8 (4.54) 80.8 (6.32) 89.8 (2.41) 90.1 (3.28) 106 (3.09)
TFMS 110 (7.01) 99.5 (8.05) 99.3 (7.09) 107 (9.75) 106 (10.4)
PFEtS 90.4 (12.1) 94.9 (6.25) 88.8 (5.44) 90.0 (7.63) 96.0 (5.53)
PFPrS 99.4 (9.37) 92.3 (8.05) 97.1 (4.87) 94.4 (7.57) 101 (4.53)
PFBS 101 (12.8) 107 (8.88) 98.2 (11.5) 94.6 (7.03) 109 (11.2)
PFPeS 111 (7.96) 106 (7.55) 108 (8.38) 106 (4.36) 111 (6.12)
PFHxS 85.5 (6.65) 89.1 (12.3) 96.1 (13.3) 96.2 (9.71) 105 (5.29)
PFHpS 87.9 (9.29) 88.0 (4.81) 90.9 (4.84) 89.1 (6.79) 94.4 (3.34)
PFOS 89.2 (9.65) 89.4 (10.7) 112 (7.14) 106 (7.94) 107 (6.53)
PFNS 86.9 (9.81) 82.7 (5.10) 108 (6.65) 107 (10.4) 108 (5.39)
PFDS 87.5 (11.9) 88.9 (9.25) 109 (7.57) 106 (9.44) 105 (8.17)
PFUdS 89.7 (10.2) 84.9 (5.13) 105 (9.17) 95.3 (10.4) 97.1 (6.65)
PFDoS 91.0 (9.86) 81.7 (6.58) 98.6 (10.6) 84.7 (8.43) 89.8 (9.51)
PFTrDS 80.5 (6.95) 83.6 (13.6) 94.6 (8.68) 84.6 (12.2) 93.0 (13.4)
4:2 FTS 101 (10.1) 113 (6.58) 108 (6.31) 112 (4.14) 112 (6.30)
6:2 FTS 111 (7.44) 99.8 (5.59) 110 (9.56) 116 (4.78) 118 (4.57)
8:2 FTS 89.4 (8.88) 86.2 (8.13) 107 (6.72) 117 (4.84) 115 (5.38)
FOSA 88.4 (8.80) 90.0 (7.86) 96.5 (13.6) 99.7 (7.60) 107 (12.2)
NMeFOSAA 89.0 (10.5) 87.9 (9.53) 101 (9.92) 102 (8.70) 103 (6.85)
NEtFOSAA 104 (9.71) 91.4 (9.41) 109 (7.39) 115 (4.19) 115 (4.33)
PFMPA 82.1 (4.74) 82.0 (3.76) 83.1 (4.58) 84.9 (4.63)
PFMBA 88.7 (12.1) 103 (12.5) 96.2 (8.93) 92.3 (9.42) 103 (6.87)
HFPO-DA 94.7 (13.7) 105 (7.55) 101 (5.29) 104 (9.62)
ADONA 117 (3.44) 108 (8.64) 108 (7.27) 104 (7.23) 108 (6.31)
PFEESA 99.7 (10.9) 110 (5.44) 106 (6.32) 100 (8.12) 109 (10.2)
9Cl-PF3ONS 84.8 (5.47) 87.8 (5.83) 83.6 (6.65) 84.4 (3.03) 86.3 (4.58)
11Cl-PF3OUdS 84.2 (7.68) 91.6 (8.41) 106 (5.69) 101 (7.79) 100 (5.06)
Capstone A 89.7 (10.4) 81.9 (7.72) 83.7 (6.37) 88.4 (9.29)
Capstone B 93.8 (11.3) 93.6 (12.4) 107 (11.8) 104 (12.7)

Real-World Sample Analysis

A total of 24 milk samples were collected from local grocery stores to assess PFAS contamination using the established workflow. Each sample was prepared in duplicate. The results revealed widespread presence of TFA, TFMS, PFBA, and PFHpA in the milk samples (Table IV). Notably, all tested soymilk samples contained high levels of PFPrA and PFBA. Long-chain compounds, including PFOA, PFOS, PFNA, PFDoA, and PFTeDA, were detected in some samples. A fluorotelomer sulfonic acid compound, 6:2 FTS, was the only PFAS identified aside from perfluoroalkyl carboxylic and sulfonic acids, and it was present in all four infant formula samples and some of the other milk samples. TFA concentrations were significantly higher and exceed the calibration range in some milk samples, necessitating sample dilution prior to extraction to obtain accurate quantification.

Table IV: Measurement of 41 Targeted PFAS in Various Milk Matrices

Concentration (µg/kg)
Ultrashort-Chain Short-Chain Long-Chain Others
Milk Samples TFA PFPrA TFMS PFBA PFHpA PFOA PFOS PFNA PFDoA PFTeDA 6:2 FTS
Dairy Milk
Whole Milk #1 2.3 nd 0.0049 nd nd nd nd nd nd nd nd
Whole Milk #2 4.3 0.035 0.065 0.087 0.0093 0.0044 nd nd nd nd nd
Whole Milk #3 4.1 nd <0.0040 0.038 <0.0040 0.0045 nd nd <0.0040 nd 0.011
Whole Milk #4 3.0 nd 0.0052 0.012 <0.0040 nd nd nd nd nd nd
2% Reduced Fat Milk #1 3.5 nd 0.012 0.023 0.0045 0.0094 0.018 <0.0040 <0.0040 <0.0040 0.0043
2% Reduced Fat Milk #2 4.0 nd 0.0052 0.015 nd nd nd nd nd nd nd
Fat-Free Milk #1 3.6 nd 0.0055 0.011 nd nd nd nd nd nd nd
Fat-Free Milk #2 3.4 nd 0.0046 0.010 <0.0040 <0.0040 nd nd nd nd 0.0041
Fat-Free Milk #3 2.4 nd 0.0076 nd nd nd nd nd nd nd nd
Plant-Based Milk
Almond Milk #1 1.8 nd 0.0043 0.017 nd nd nd nd nd nd nd
Almond Milk #2 2.2 nd 0.0070 0.021 <0.0040 <0.0040 nd nd <0.0040 nd <0.0040
Almond Milk #3 5.3 nd 0.013 0.039 <0.0040 nd nd nd nd nd nd
Oat Milk #1 7.2 nd 0.027 0.016 <0.0040 0.0052 0.0086 nd nd nd 0.055
Oat Milk #2 11 nd 0.021 0.019 nd nd nd nd nd nd 0.0053
Soy Milk #1 24 0.52 0.016 0.21 <0.0040 nd nd nd nd nd nd
Soy Milk #2 11 0.26 0.013 0.10 <0.0040 nd nd nd nd nd nd
Soy Milk #3 5.6 0.088 0.016 0.069 nd nd nd nd nd nd nd
Coconut Milk #1 1.1 nd 0.0047 0.013 <0.0040 nd nd nd nd nd nd
Coconut Milk #2 1.0 nd 0.0043 nd <0.0040 0.0053 nd nd nd nd 0.0053
Infant Formula
Formula #1 1.0 nd <0.0040 nd nd nd nd nd nd nd 0.0064
Formula #2 0.4 nd <0.0040 nd <0.0040 nd nd nd nd nd 0.0074
Formula #3 0.8 nd <0.0040 0.012 <0.0040 <0.0040 nd nd nd nd 0.0050
Formula #4 1.2 nd 0.0069 0.011 <0.0040 0.0050 nd nd nd nd 0.012
nd = not detected

Conclusion

This study developed a simple, robust workflow for comprehensive PFAS analysis in various liquid milk matrices, successfully incorporating ultrashort-chain PFAS along with more commonly analyzed compounds. The optimized sample preparation protocol, combined with a sensitive LC method, enabled effective extraction and quantification of 41 PFAS with high accuracy and precision. The LC method leveraged a distinctive Ultra Inert IBD column, which features a polar-embedded alkyl stationary phase and an inert surface coating, providing enhanced retention for ultrashort-chain compounds and minimized analyte interaction to achieve increased sensitivity. Application of this workflow to commercial milk samples provided valuable insights into PFAS contamination across different milk sources. These findings highlight the importance of integrating ultrashort-chain PFAS into routine monitoring of PFAS in food products and offer a practical approach to support future food safety research and regulatory initiatives.  

References

  1. J. York, Analysis of PFAS in milk by LC-MS/MS, Application note, FSAN4338-UNV, Restek Corporation, 2024. https://www.restek.com/articles/analysis-of-pfas-in-milk-by-lc-ms-ms
  2. S.H. Liang, Incorporating ultrashort-chain compounds into comprehensive PFAS analysis in waters, Application note, EVAN4402-UNV, Restek Corporation, 2025. https://www.restek.com/articles/incorporating-ultrashort-chain-compounds-into-comprehensive-pfas-analysis-in-waters
  3. S.H. Liang, J. Steimling, C1-C10 PFAS analysis in human plasma and serum, Application note, CFAN4273A-UNV, Restek Corporation, 2025. https://www.restek.com/articles/c1-c10-pfas-analysis-in-human-plasma-and-serum
  4. European Union Reference Laboratory for halogenated POPs in Feed and Food. Guidance Document on Analytical Parameters for the Determination of Per- and Polyfluoroalkyl Substances (PFAS) in Food and Feed. Version 1.2. May 2022. https://eurl-pops.eu/news/guidance-document-pfas/guidance-document-pfas

Products Mentioned


Ultra Inert IBD, 3 µm, 100 x 2.1 mm HPLC Column
Ultra IBD, 3 µm, 150 x 2.1 mm HPLC Column
PFAS 28 Calibration Standard, 1 µg/mL, Methanol (1 mM KOH), 1 mL/ampul
Empty Centrifuge Tubes, 50 mL, Polypropylene w/Cap, 50-pk.

Author

  • Shun-Hsin Liang, PhD

    Shun-Hsin is a senior principal scientist in LC Solutions at Restek. He received his bachelor’s degree from the National Taiwan University in 1988 and obtained his PhD from Michigan State University in 1996. He performed postdoctoral research at the University of Michigan from 1996 to 2000 for oncology studies. In 2001, he was appointed as research faculty at The Pennsylvania State University and focused on molecular toxicology research. In 2006, he joined MPI Research Inc. as a senior research scientist and was a study director for GLP analytical projects. In 2013, Dr. Liang joined the LC Solutions department at Restek and specialized in developing application methods across the fields of environmental, food safety, and life sciences.

    View all posts
FSAN5396